LEADER 02290nam  2200541   450 
001 9910787504303321
005 20230803031540.0
010   $a1-60805-718-6
035   $a(CKB)2670000000428166
035   $a(EBL)1426930
035   $a(OCoLC)862103783
035   $a(SSID)ssj0001127417
035   $a(PQKBManifestationID)11667137
035   $a(PQKBTitleCode)TC0001127417
035   $a(PQKBWorkID)11151142
035   $a(PQKB)10613785
035   $a(MiAaPQ)EBC1426930
035   $a(EXLCZ)992670000000428166
100   $a20111102h20132013  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAnti-allergy agents /$feditor, Atta-ur-Rahman
210  1$aSharjah, United Arab Emirates :$cBentham Science Publishers,$d[2013]
210  4$dİ2013
215   $a1 online resource (389 p.)
225 0 $aFrontiers in clinical drug research ;$v1
300   $aDescription based upon print version of record.
311   $a1-60805-719-4 
320   $aIncludes bibliographical references and index.
327   $aCover; Title; EUL; Preface; List of Contributor; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Chatper 09; Index
330   $aThis is an exciting eBook series comprising a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs.
410  0$aFrontiers in Clinical Drug Research - Anti-Allergy Agents
606   $aAntiallergic agents
606   $aImmunopharmacology
615  0$aAntiallergic agents.
615  0$aImmunopharmacology.
676   $a615.19
701   $aRahman$b Atta-ur-$f1942-$0544456
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910787504303321
996   $aAnti-allergy agents$93773028
997   $aUNINA